FIELD: organic chemistry, medicine, phthisiology, chemical-pharmaceutical industry. SUBSTANCE: invention proposes an agent that is a conjugate of isoniazide with dextran of molecular mass 65-75 kDa of the following formula:
where R1 is H, glucose residue or polyglycosyl residue as given in a drawing; R2 is a residue of isoniazide of the formula: -NH-NH-
; R3 is hydroxyl group. EFFECT: decreased hepatotoxicity of antituberculosis agent isoniazide, retained high-therapeutic effectiveness of isoniazide. 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT FOR TREATMENT OF TUBERCULOSIS WITH LOW LEVEL OF FIBROTIC COMPLICATIONS | 2000 |
|
RU2185166C2 |
| METHOD OF TREATMENT THE GENERAL TUBERCULOSIS PROCESS IN EXPERIMENT | 1993 |
|
RU2087146C1 |
| ISONIAZID-DEXTRAN CONJUGATE AND APPLICATION THEREOF | 1999 |
|
RU2163120C1 |
| PHARMACEUTICAL TUBERCULOSIS COMPOSITION | 2008 |
|
RU2372914C1 |
| METHOD FOR PRODUCING PROLONGED ACTION ISONIASIDE | 2000 |
|
RU2192865C2 |
| METHOD FOR STIMULATING HEPATIC TISSUE REPAIR | 1999 |
|
RU2185835C2 |
| SECONDARY DISORGANIZATION OF CONNECTIVE TISSUE SIMULATION TECHNIQUE | 2005 |
|
RU2307397C2 |
| SALT OF BIS(OXYMETHYL)PHOSPHINIC ACID WITH ISONICOTINIC ACID HYSRAZIDE (TUBOPHEN) HAVING ANTITUBERCULOSIS ACTION AND METHOD FOR PRODUCTION THEREOF | 2005 |
|
RU2281939C1 |
| METHOD FOR TREATING MEDICINE-RESISTANT TUBERCULOSIS | 2001 |
|
RU2197965C1 |
| COMBINED ANTITUBERCULOUS COMPOSITION | 2009 |
|
RU2413517C1 |
Authors
Dates
2001-06-20—Published
1999-12-06—Filed